Hydroxychloroquine sulfate (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Hydroxychloroquine sulfate drug offered from Cadila Healthcare Limited. This Antirheumatic Agent [EPC],Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Hydroxychloroquine sulfate |
SUBSTANCE NAME: | HYDROXYCHLOROQUINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antirheumatic Agent [EPC],Antimalarial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-01-03 |
END MARKETING DATE: | 0000-00-00 |
Hydroxychloroquine sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Hydroxychloroquine sulfate from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2008-01-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-633_b356ba48-4115-49ab-93e7-26a45eca9175 |
PRODUCT NDC: | 65841-633 |
APPLICATION NUMBER: | ANDA040657 |
Other HYDROXYCHLOROQUINE SULFATE Pharmaceutical Manufacturers / Labelers: